Utah Approved Pilot for AI Drug Prescriptions
The state sandbox program now allows an AI service to evaluate patients for acne treatments under clinician supervision.
Updated on Oct. 5, 2026 in Artificial Intelligence
Live Poll
Do you trust artificial intelligence to issue medical prescriptions without direct human review?
Utah regulators have launched a pilot program allowing Nolla Health to use AI for patient assessments and drug prescriptions. The initiative operates within the state's AI sandbox, which waives specific regulations for under-supervised technology testing.
Why it matters
The pilot represents a significant expansion of Utah's regulatory sandbox, testing whether AI can safely handle clinical diagnostics and medication authorizations. This move could redefine state oversight for healthcare-focused artificial intelligence products.
Nolla Health uses a structured patient intake process combined with proprietary skin photo analysis to assess eligibility for acne treatment. While currently integrated with manual clinician sign-off, the system is designed to eventually bypass human review.
The players
Nolla Health
This health-tech company focuses on automating medical assessments and prescriptions using structured data and artificial intelligence.
Utah Office of Artificial Intelligence Policy
This state agency manages the AI sandbox program and is responsible for waiving specific regulatory barriers to facilitate the testing of new AI products.
The details
Nolla Health is operating its AI-powered diagnostic service under the supervision of the Utah Office of Artificial Intelligence Policy. The service currently limits its scope to acne assessment, but the company aspires to expand its AI evaluation model to a wider variety of medical conditions.
Timeline
Nolla Health raised $4.5 million in funding during 2025.
Utah regulators officially announced the AI pilot program on October 5, 2026.
The Tech Race
This pilot program marks a shift in the ongoing competition to integrate AI into primary healthcare by replacing traditional clinical workflows with automated diagnostics. It positions Utah as a testing ground for technologies seeking to bypass long-standing, human-centric medical regulations.
Patients participating in the pilot may experience a faster intake process for acne treatment compared to traditional clinic visits. However, users must be aware that the system is currently in a testing phase where clinical sign-off is still a mandatory requirement.
The takeaway
The Utah pilot signals a future where routine medical assessments are increasingly handled by algorithms rather than humans. Patients should remain vigilant about the role of clinician oversight in their digital health experiences as these regulations evolve.
Further reading
Learn more about the latest innovations and oversight in Artificial Intelligence.
Live Poll
Do you trust artificial intelligence to issue medical prescriptions without direct human review?
